Finally, medications like denosumab, which is a monoclonal antibody that inhibits osteoclasts, and raloxifene, which is a selective estrogen receptor modulator, can be used for postmenopausal osteoporosis.
最后,地诺单抗等药物作为单克隆抗体可抑制破骨细胞;雷洛昔芬,一种有选择性的雌激素受体调节器,可以被用于绝经后骨质疏松。